Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 125

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals

Kaye, David M., Preovolos, Arthur, Marshall, Tanneale, Byrne, Melissa, Hoshijima, Masahiko, Hajjar, Roger, Mariani, Justin A., Pepe, Salvatore, Chien, Kenneth R., Power, John M. · 2007 · Journal of the American College of Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2007.03.047

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Bukhari, 2005, Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications, Expert Rev Cardiovasc Ther, 3, 85, 10.1586/14779072.3.1.85 · DOI
  2. Sesti, 2004, Gene therapy in congestive heart failure, Circulation, 110, 242, 10.1161/01.CIR.0000137593.62669.67 · doi:10.1161/01.cir.0000137593.62669.67
  3. Hoshijima, 2005, Gene therapy targeted at calcium handling as an approach to the treatment of heart failure, Pharmacol Ther, 105, 211, 10.1016/j.pharmthera.2004.10.006 · DOI
  4. MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, 4, 566, 10.1038/nrm1151 · DOI · Paper page
  5. Hasenfuss, 2002, Calcium cycling in congestive heart failure, J Mol Cell Cardiol, 34, 951, 10.1006/jmcc.2002.2037 · DOI · Paper page
  6. Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
  7. Chien, 2000, Genomic circuits and the integrative biology of cardiac diseases, Nature, 407, 227, 10.1038/35025196 · DOI · Paper page
  8. Chien, 2003, Calcium and heart failure: the cycle game, Nat Med, 9, 508, 10.1038/nm0503-508 · DOI
  9. Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat Med, 8, 864, 10.1038/nm739 · DOI · Paper page
  10. Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J Clin Invest, 113, 727, 10.1172/JCI18716 · DOI · Paper page
  11. Williams, 2004, Viral-based myocardial gene therapy approaches to alter cardiac function, Annu Rev Physiol, 66, 49, 10.1146/annurev.physiol.66.032102.141555 · DOI
  12. Thompson, 2004, Gene therapy for heart failure, Ann Med, 36, 106, 10.1080/17431380410032652 · DOI
  13. De Grand, 2003, An operational near-infrared fluorescence imaging system prototype for large animal surgery, Tech Cancer Res Treat, 2, 553, 10.1177/153303460300200607 · DOI · Paper page
  14. Kaye, 2003, Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation, Circulation, 108, 1795, 10.1161/01.CIR.0000096051.23734.28 · DOI
  15. Chu, 1988, Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle, Methods Enzymol, 157, 36, 10.1016/0076-6879(88)57066-0 · DOI
  16. Fabiato, 1988, Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands, Methods Enzymol, 157, 378, 10.1016/0076-6879(88)57093-3 · DOI · Paper page
  17. Patton, 2004, Some precautions in using chelators to buffer metals in biological solutions, Cell Calcium, 35, 427, 10.1016/j.ceca.2003.10.006 · DOI · Paper page
  18. Seidler, 1989, Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum, J Biol Chem, 264, 17816, 10.1016/S0021-9258(19)84646-X · DOI · Paper page
  19. Weiss, 1997, In situ histochemical detection of beta-galactosidase activity in lung: assessment of X-gal reagent in distinguishing LacZ gene expression and endogenous beta-galactosidase activity, Hum Gene Ther, 8, 1545, 10.1089/hum.1997.8.13-1545 · DOI
  20. Zsengeller, 2000, Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection, J Virol, 74, 9655, 10.1128/JVI.74.20.9655-9667.2000 · DOI
  21. Tomaselli, 1999, Electrophysiological remodeling in hypertrophy and heart failure, Cardiovasc Res, 42, 270, 10.1016/S0008-6363(99)00017-6 · DOI · Paper page
  22. Schwinger, 1997, Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium, J Pharmacol Exp Ther, 283, 286, 10.1016/S0022-3565(24)36993-9 · DOI
  23. Miyamoto, 2000, Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure, Proc Natl Acad Sci U S A, 97, 793, 10.1073/pnas.97.2.793 · DOI · Paper page
  24. Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ Res, 78, 839, 10.1161/01.RES.78.5.839 · DOI
  25. Nef, 2006, Reduced sarcoplasmic reticulum Ca2+-ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium, Mol Cell Biochem, 282, 53, 10.1007/s11010-006-1171-7 · DOI
  26. Schwinger, 1999, Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation, J Mol Cell Cardiol, 31, 479, 10.1006/jmcc.1998.0897 · DOI · Paper page
  27. Prestle, 1999, Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart, Cardiovasc Res, 43, 323, 10.1016/S0008-6363(99)00119-4 · DOI
  28. He, 1999, Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility, Circulation, 100, 974, 10.1161/01.CIR.100.9.974 · DOI
  29. Eizema, 2000, Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1–responsive cardiac promoter, Circulation, 101, 2193, 10.1161/01.CIR.101.18.2193 · DOI
  30. Dieterle, 2005, Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure, Cardiovasc Res, 67, 678, 10.1016/j.cardiores.2005.04.029 · DOI
  31. Song, 2003, Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy, J Clin Invest, 111, 859, 10.1172/JCI200316738 · DOI
  32. Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J Clin Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
  33. Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
  34. Weitzman, 2005, Breaking the barriers to global gene delivery, Nat Biotechnol, 23, 305, 10.1038/nbt0305-305 · DOI
  35. Leiden, 2000, Human gene therapy: the good, the bad, and the ugly, Circ Res, 86, 923, 10.1161/01.RES.86.9.923 · doi:10.1161/01.res.86.9.923
  36. Davidson, 2001, Cardiac gene delivery with cardiopulmonary bypass, Circulation, 104, 131, 10.1161/01.CIR.104.2.131 · doi:10.1161/01.cir.104.2.131
  37. Roth, 2004, Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirus, Hum Gene Ther, 15, 989, 10.1089/hum.2004.15.989 · DOI
  38. Raake, 2004, Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery, J Am Coll Cardiol, 44, 1124, 10.1016/j.jacc.2004.05.074 · DOI
  39. del Monte, 2004, Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling, Proc Natl Acad Sci U S A, 101, 5622, 10.1073/pnas.0305778101 · DOI · Paper page
  40. Zhu, 2005, Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer, Circulation, 112, 2650, 10.1161/CIRCULATIONAHA.105.565598 · DOI
  41. Kawamoto, 2005, Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter, Mol Ther, 11, 980, 10.1016/j.ymthe.2005.02.009 · DOI
  42. Wang, 2005, AAV-mediated gene transfer for treatment of hemophilia, Curr Gene Ther, 5, 349, 10.2174/1566523054065048 · DOI
  43. Bessis, 2004, Immune responses to gene therapy vectors: influence on vector function and effector mechanisms, Gene Ther, 11, S10, 10.1038/sj.gt.3302364 · DOI · Paper page

Cited by

See all 125

Metadata

Authors
Kaye, D. M., Preovolos, A., Marshall, T., Byrne, M., Hoshijima, M., Hajjar, R., Mariani, J. A., Pepe, S., Chien, K. R., & Power, J. M.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2007-07
Volume
50
Issue
3
Pages
253-260
ISSN
0735-1097
Cited by
125
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.